✦ LIBER ✦

Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2

✍ Scribed by Loukola, Anu; Chadha, Monica; Penn, Sharron G; Rank, David; Conti, David V; Thompson, Deborah; Cicek, Mine; Love, Brad; Bivolarevic, Vesna; Yang, Qiner

Book ID: 110025510
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 241 KB
Volume: 12
Category: Article
ISSN: 1018-4813
DOI: 10.1038/sj.ejhg.5201101

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CYP3A4, CYP3A5, and CYP3A43 Genotypes an

CYP3A4, CYP3A5, and CYP3A43 Genotypes and Haplotypes in the Etiology and Severity of Prostate Cancer

✍ Zeigler-Johnson, C. 📂 Article 📅 2004 🏛 American Association for Cancer Research 🌐 English ⚖ 135 KB

Differences in CYP3A4⁎1G genotype distri

Differences in CYP3A4⁎1G genotype distribution and haplotypes of CYP3A4, CYP3A5 and CYP3A7 in 3 Chinese populations

✍ Jing Du; Lan Yu; Lei Wang; Aiping Zhang; Anli Shu; Lingyun Xu; Mingsheng Xu; Yon 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 122 KB

CYP17 , SRD5A2 , CYP1B1 , and CYP2D6 Gen

CYP17 , SRD5A2 , CYP1B1 , and CYP2D6 Gene Polymorphisms with Prostate Cancer Risk in North Indian Population

✍ Sobti, R.C.; Onsory, Khadijeh; Al-Badran, Adnan Issa; Kaur, Pushpinder; Watanabe 📂 Article 📅 2006 🏛 Mary Ann Liebert 🌐 English ⚖ 89 KB

Polymorphisms in the cytochromeP450 gene

Polymorphisms in the cytochromeP450 genesCYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1,CYP19A1and colorectal cancer risk

✍ Lara Bethke; Emily Webb; Gabrielle Sellick; Matthew Rudd; Stephen Penegar; Laura 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 254 KB

Ethnic Differences in the Frequency of P

Ethnic Differences in the Frequency of Prostate Cancer Susceptibility Alleles at SRD5A2 and CYP3A4

✍ Zeigler-Johnson, C.M.; Walker, A.H.; Mancke, B.; Spangler, E.; Jalloh, M.; McBri 📂 Article 📅 2002 🏛 S. Karger AG 🌐 English ⚖ 103 KB

Evaluation of the influence of polymorph

Evaluation of the influence of polymorphic variants CYP1A1*2B, CYP1B1*2, CYP3A4*1B, GSTM1*0, and GSTT1*0 in prostate cancer

✍ Iara S. Rodrigues; Hellen Kuasne; Roberta Losi-Guembarovski; Paulo E. Fuganti; É 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 244 KB